Answer Summary

Members expressed cautious optimism about Tonmya, a new fibromyalgia drug expected for approval in late 2025, with several noting it appears... Read more

Members expressed cautious optimism about Tonmya, a new fibromyalgia drug expected for approval in late 2025, with several noting it appears to be a long-acting form of cyclobenzaprine (generic Flexeril) that dissolves under the tongue and is designed specifically for fibromyalgia with fewer side effects. Many community members described already taking cyclobenzaprine or similar muscle relaxants for sleep and widespread pain relief, sharing that it helps reduce nighttime muscle cramps and restless legs. A recurring theme was hope that this non-opioid option could finally offer meaningful relief after years without new treatment options, though some members expressed concern about potential intolerances to pain medications.